Search research articles
Contact Us
Filters
Showing results (761-770 of 952) with videos related to
Page
of 96
Sort By:
Organic & Biomolecular Chemistry
|
June 4, 2024
Semisynthesis and antitumor activity of endertiin B and related triterpenoids from <i>Ganoderma lucidum</i>
Yu Liu, Hong-Kai Wen, Rui-Xuan Xu, et al.
The Journal of Cardiovascular Nursing
|
May 8, 2020
Physical Activity and Factors Affecting Its Maintenance Among Patients With Coronary Heart Disease Not Undergoing Cardiac Rehabilitation in China
Jianhui Wang, Huaping Liu, Changxiang Chen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 22, 2012
[Effect of cyclophosphamide on murine bone marrow hematopoietic cells and its possible mechanism]
Jie Tian, Pei Yu, Wen-Xuan Sun, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 28, 2019
CORRIGENDUM: Novel Risk Biomarker for Infective Endocarditis Patients With Normal Left Ventricular Ejection Fraction
Xue-Biao Wei, Feng Chen, Jie-Leng Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 22, 2017
[Relationship between High Expression of c-FLIP and Drug Resistance of Leukemia Cells]
Jia Liu, Ying Wang, Sai-Sai Li, et al.
Cancers
|
January 11, 2025
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study
Ramya Muddasani, Helena T Wu, Shwe Win, et al.
Journal of Environmental Sciences (China)
|
July 14, 2023
Temporal patterns of algae in different urban lakes and their correlations with environmental variables in Xi'an, China
Shengnan Chen, Hanyan Liu, Haihan Zhang, et al.
Zhonghua Nei Ke Za Zhi
|
February 26, 2005
[Anti-hypertensive effect of rosiglitazone in non-diabetic essential hypertension]
Guang-wei Li, Jin-ping Wang, Chun-mei Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 24, 2019
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer
Yan Xing, Gitasha Chand, Changchun Liu, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Page
of 96
Search research articles
Search
Showing results (761-770 of 952) with videos related to
Sort By:
Page
of 96
Organic & Biomolecular Chemistry
|
June 4, 2024
Semisynthesis and antitumor activity of endertiin B and related triterpenoids from <i>Ganoderma lucidum</i>
Yu Liu, Hong-Kai Wen, Rui-Xuan Xu, et al.
The Journal of Cardiovascular Nursing
|
May 8, 2020
Physical Activity and Factors Affecting Its Maintenance Among Patients With Coronary Heart Disease Not Undergoing Cardiac Rehabilitation in China
Jianhui Wang, Huaping Liu, Changxiang Chen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 22, 2012
[Effect of cyclophosphamide on murine bone marrow hematopoietic cells and its possible mechanism]
Jie Tian, Pei Yu, Wen-Xuan Sun, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 28, 2019
CORRIGENDUM: Novel Risk Biomarker for Infective Endocarditis Patients With Normal Left Ventricular Ejection Fraction
Xue-Biao Wei, Feng Chen, Jie-Leng Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
December 22, 2017
[Relationship between High Expression of c-FLIP and Drug Resistance of Leukemia Cells]
Jia Liu, Ying Wang, Sai-Sai Li, et al.
Cancers
|
January 11, 2025
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study
Ramya Muddasani, Helena T Wu, Shwe Win, et al.
Journal of Environmental Sciences (China)
|
July 14, 2023
Temporal patterns of algae in different urban lakes and their correlations with environmental variables in Xi'an, China
Shengnan Chen, Hanyan Liu, Haihan Zhang, et al.
Zhonghua Nei Ke Za Zhi
|
February 26, 2005
[Anti-hypertensive effect of rosiglitazone in non-diabetic essential hypertension]
Guang-wei Li, Jin-ping Wang, Chun-mei Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 24, 2019
Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer
Yan Xing, Gitasha Chand, Changchun Liu, et al.
Investigational New Drugs
|
March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Page
of 96